Tang Capital Management’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
VCM
VPM
N
Tang Capital Management's ALT Position: Q1 2026 in Review
Tang Capital Management reduced its Altimmune (ALT) stake by 69% in Q1 2026, selling an estimated $6.22M and leaving 666,022 shares worth $2.05M. The position accounts for 0.1% of the portfolio, ranked #45.
Tang Capital Management first reported a position in ALT in Q2 2021 and has held it in 20 quarters since. The position peaked at $44.4M in Q4 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.
- Tang Capital Management held 666,022 shares of Altimmune worth $2.05M as of Q1 2026.
- Tang Capital Management sold 1,465,285 Altimmune shares in Q1 2026, an estimated $6.22M.
- Altimmune made up 0.1% of Tang Capital Management's portfolio in Q1 2026, its #45 holding.
- Tang Capital Management first reported a position in Altimmune in Q2 2021 and has held it in 20 quarters since.
- Tang Capital Management's Altimmune position peaked at $44.4M in Q4 2022.
- 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.
Based on Tang Capital Management's 13F filing for Q1 2026, filed 15 May 2026.